series c financing - Robuta Search

https://www.businesswire.com/news/home/20200916005913/en/LAVA-Therapeutics-Announces-%2483-million-Series-C-Financing-to-Advance-Novel-Immuno-Oncology-Programs LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs series c financing lava therapeutics announces million https://atlasbulletin.com/special-report-on-digital-smart-ais-usd-70-million-series-c-financing-completed-in-july-2026/ Special Report on Digital Smart-AI’s USD 70 Million Series C Financing Completed in July 2026 –... series c financing special report on digital smart usd Sponsored https://www.sexyfans.app/enter.php?prg=1&id=robuta&t=best&ad_id=sexyfans_300x250_r.jpg Sexyfans.app - Only Fans of Dating Apps The only dating app for fans to meet up with local content creators. https://cerevasc.com/cerevasc-inc-announces-over-subscribed-85-million-series-c-financing-to-advance-its-novel-eshunt-system-for-the-treatment-of-normal-pressure-hydrocephalus/ CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel... Jun 4, 2026 - CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus... series c financing over subscribed inc announces million https://www.fyb.de/en/shift-technology-60-million-in-series-c-financing-round/ Shift Technology: $60 million in Series C financing round - FYB Financial Yearbook Mar 6, 2019 - Berlin/Paris — Shift Technology, a provider of AI solutions for fraud identification and claims processing in the global insurance industry,... series c financing shift technology million round https://orthospinenews.com/2017/06/08/trice-medical-closes-19-3-million-series-c-financing-to-address-increased-demand-for-mi-eye/ Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eye –... series c financing trice medical closes million https://www.newswire.co.kr/newsRead.php?no=982324 ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a... Jan 9, 2024 - ENYO Pharma (“ENYO”) announced that it has received clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administra series c financing enyo pharma announces million https://www.vcnewsdaily.com/access/getarticle.php?aid=lnzvzzhgnh Venture Capital News: Obsidian Therapeutics Announces $160.5M in Series C Financing CAMBRIDGE, MA, Obsidian Therapeutics, a clinical-stage biotechnology company pioneering engineered cell and gene therapies, announced it has closed a... series c financing venture capital news obsidian therapeutics https://optimaldose.ciscientists.com/tscan-therapeutics-announced-100-m-series-c-financing/ TScan Therapeutics announced $100 M Series C financing - Optimal Dose Jan 29, 2021 - T cell targeting therapies - January 2021 T cell targeting therapies - January 2021 TScan Therapeutics announced $100 million Series C financing managed by... series c financing therapeutics announced optimal dose https://realinvestplan.com/2026/07/10/special-report-on-digital-smart-ais-usd-70-million-series-c-financing-completed-in-july-2026/ Special Report on Digital Smart-AI’s USD 70 Million Series C Financing Completed in July 2026 series c financing special report on digital smart usd https://am.gs.com/en-jp/institutions/news/press-release/2025/growth-equity-tines Tines, the leader in AI-powered workflows, announced $125 million in Series C financing led by... Tines, the leader in AI-powered workflows, announced $125 million in Series C financing led by Growth Equity at Goldman Sachs Alternatives. ai powered workflows series c financing the leader tines announced https://xontogeny.com/news/avalyn-raises-175-million-in-oversubscribed-series-c-financing-to-advance-inhaled-pulmonary-fibrosis-programs-into-later-stage-clinical-studies/ Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary... SEATTLE – September 27, 2023 – Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted inhalation therapies for series c financing avalyn raises million oversubscribed https://www.lyrahealth.com/announcement/lyra-health-announces-closing-of-75m-series-c-financing/ Lyra Health Announces Closing of $75M Series C Financing | Lyra Health Mar 1, 2025 - Lyra Health, a leading provider of innovative mental health benefits for employers, announced a Series C financing round of $75 million. series c financing lyra health announces closing